SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-026589
Filing Date
2021-11-15
Accepted
2021-11-15 06:30:56
Documents
69
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20210930_10q.htm   iXBRL 10-Q 1544975
2 EXHIBIT 2.1 ex_306800.htm EX-2.1 815807
3 EXHIBIT 10.1 ex_300099.htm EX-10.1 296207
4 EXHIBIT 10.2 ex_300100.htm EX-10.2 281936
5 EXHIBIT 10.3 ex_306801.htm EX-10.3 172874
6 EXHIBIT 10.4 ex_306589.htm EX-10.4 37832
7 EXHIBIT 31.1 ex_300101.htm EX-31.1 7970
8 EXHIBIT 31.2 ex_300102.htm EX-31.2 8697
9 EXHIBIT 32.1 ex_300103.htm EX-32.1 6098
  Complete submission text file 0001437749-21-026589.txt   7974014

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA acrx-20210930.xsd EX-101.SCH 53984
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20210930_cal.xml EX-101.CAL 38594
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20210930_def.xml EX-101.DEF 355629
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20210930_lab.xml EX-101.LAB 306021
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20210930_pre.xml EX-101.PRE 376563
15 EXTRACTED XBRL INSTANCE DOCUMENT acrx20210930_10q_htm.xml XML 901746
Mailing Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545
Business Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 211406174
SIC: 2834 Pharmaceutical Preparations